EP-1229: Overall Treatment Time and Toxicity of IMAT with Integrated Boost for Intermediate or High-Risk Prostate CancerF. Ferrer, M. Mendez,H. Letelier,A. Boladeras,R. Piñeiro,C. Chiruzzi,M. Galdeano,D. Najjari,I. Sancho,R. Chavez,C. Picon,J. Pera,F. GuedeaRadiotherapy and oncology（2015）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
